Chapter 2: Conceptual Models of Addiction

Historical and societal roots

The moral model dominated long before modern psychiatry and neuroscience, framing heavy drinking or drug use as vice, sin, weak will, or defective character. In the U.S., this framing intertwined with temperance movements and later with punitive drug control, helping justify prohibitionist and criminal-legal responses (Berridge, 2013; Courtwright, 2001; Levine, 1978; Musto, 1999; White, 1998). Part of the model’s durability is its simplicity. If substance use reflects a defect of character, then punishment follows as the obvious remedy, and no further explanation is required.

Core assumptions and mechanisms

Substance use is viewed primarily as voluntary misconduct. “Recovery” becomes moral reform — repentance, willpower, discipline — and relapse is read as personal failure rather than an expected feature of chronic behavior change.

Evidence-based and societal impact

Modern stigma research consistently shows that stigmatizing attitudes toward people with substance use disorders correlate with greater blame, stronger desire for social distance, and greater support for punitive policies over treatment-oriented ones (Kennedy-Hendricks et al., 2017). Those attitudes also deter treatment entry (Cheetham et al., 2022).

Influence on individuals

Many people internalize this model as shame and self-stigma, delaying disclosure and treatment engagement. Clinically, shame can sometimes motivate short-term abstinence, but as a primary behavior-change lever, it is unstable and often causes more harm than it prevents when paired with punishment or social exclusion.

Treatment and policy fit

This model aligns with abstinence-only moral reform, coerced treatment, and carceral approaches. It can also align with certain recovery communities’ language of “character defects,” though many mutual-help settings explicitly soften blame by emphasizing acceptance and community support.

Historical and societal roots

Sociocultural models grew from sociology and anthropology’s insistence that drug effects and the course of addiction are not just pharmacological. Zinberg’s (1984) “drug, set, and setting” is a classic statement: the same substance can yield very different patterns depending on meaning, norms, and context. Harm reduction scholarship also pushed the profession to analyze environments, not just individuals, through frameworks like the “risk environment” (Rhodes, 2002). Harm reduction is taken up as a policy and practice approach in its own right in Chapters 5 and 6.

Core assumptions and mechanisms

Substance use is shaped by social learning, peer networks, cultural scripts, availability, policy, and family systems. Risk concentrates where stressors — poverty, violence exposure — opportunity structures, and limited healthcare access intersect. Family influence operates via modeling, attachment disruptions, inconsistent boundaries, and intergenerational stress.

Evidence-based and societal impact

Large prevention literatures identify family management, parental substance misuse, peer norms, school bonding, and neighborhood context as major risk and protective factors for substance problems (Galea et al., 2004; Hawkins et al., 1992). Reviews also document significant impacts on children exposed to parental substance misuse and highlight protective factors and intervention targets (Velleman & Templeton, 2007).

Influence on individuals

This model can reduce “I’m broken” narratives by reframing use as an understandable adaptation to a social ecology. It also supports interventions that change contexts rather than only demanding intrapsychic change. The downside is that people may feel their situation is structurally determined and therefore hopeless if supports are absent — a policy failure more than a clinical one.

Treatment and policy fit

Family-based prevention, community coalitions, culturally responsive treatment, structural interventions such as housing and employment access, and harm reduction strategies naturally align with this model.

Historical and societal roots

Psychological explanations gained prominence alongside the expansion of clinical psychology and psychiatry in the 20th century. Early formulations drew from learning theory, particularly conditioning and cue-reactivity, while later developments incorporated cognitive models focused on expectancies and coping. Psychodynamic interpretations and contemporary approaches to emotion regulation further shaped how substance use came to be understood within individual experience.

Core assumptions and mechanisms

This model centers on the idea that substance use is tied to patterns of thought, emotion, and behavior that develop over time. The notion of an “addictive personality” has been widely discussed, yet the evidence does not support a single, universal personality type. Instead, research points to probabilistic trait patterns, with higher levels of disinhibition and antagonism and lower levels of conscientiousness associated with increased risk (Kotov et al., 2010; Malouff et al., 2007). The self-medication hypothesis extends this understanding by suggesting that substances are used as a means of regulating distress, including painful affect, disrupted self-esteem, and interpersonal strain.

Evidence-based and societal impact

The absence of a singular addictive personality has shifted the focus of research toward dimensional traits and functional patterns rather than fixed identities. Evidence related to the self-medication hypothesis remains mixed across diagnoses and substances, yet findings consistently indicate that subjective distress is associated with initiation, escalation, and relapse risk.

Influence on individuals

Psychological models tend to feel less condemning than moral explanations and more actionable than purely biological accounts because they focus on how individuals interpret their behavior and respond to distress. This can support insight into triggers, coping patterns, and emotional regulation. At the same time, it can narrow attention to the individual, framing broader social and structural pressures as personal coping difficulties.

Treatment and policy fit

This model aligns with evidence-supported approaches such as cognitive-behavioral therapies and relapse prevention strategies that target thought patterns, behavioral responses, and coping skills. It also supports integrated treatment for co-occurring conditions such as trauma, depression, and anxiety.

Historical and societal roots

The disease concept of alcoholism gained institutional force in the mid-20th century through the convergence of medicalization movements and the growing influence of Alcoholics Anonymous. E. M. Jellinek (1960) formalized alcoholism as a disease entity with recognizable stages and a predictable course. Later, the “brain disease” framing became prominent within U.S. public health discourse (Leshner, 1997), positioning addiction within a biomedical narrative that emphasized underlying neurological processes. That framing has itself been contested, with critics arguing it overstates what neuroscience can currently explain about who develops a disorder and who recovers (Hall et al., 2015).

Core assumptions and mechanisms

Addiction is conceptualized as a chronic, relapsing condition involving enduring changes in brain systems related to reward, stress, and self-regulation. Contemporary neuroscience describes a cycle that moves through intoxication, withdrawal with negative affect, and ongoing preoccupation or craving, each associated with changes in specific neural pathways.

Evidence-based and societal impact

Comparative analyses suggest that substance dependence shares key features with other chronic health conditions, including the interaction of genetic and environmental influences, patterns of relapse, and the need for sustained management rather than short-term intervention. Genetic research supports substantial heritability across several substance use disorders (Goldman et al., 2005; Verhulst et al., 2015). Section 10.6 returns to the word relapse itself, explaining why much of the profession now prefers recurrence.

Influence on individuals

For many individuals, the disease model reduces shame and increases willingness to seek help by reframing substance use as a treatable condition rather than a personal failing. Meta-analytic evidence bears this out only in part. Biogenetic explanations of psychological problems do lower blame, but they also raise pessimism about recovery and, in experimental studies, perceptions of dangerousness (Kvaale et al., 2013a, 2013b). The model can also shape identity in ways that feel fixed or limiting, particularly when the emphasis on chronicity is interpreted as a loss of agency.

Treatment and policy fit

This model aligns with approaches that emphasize long-term management, including medication for opioid and alcohol use disorders, ongoing monitoring, and integrated care systems designed to support sustained recovery over time.

Historical and societal roots

The developmental life-course model emerged from longitudinal research in sociology, psychology, and public health that demonstrated that substance use patterns are not static but change over time in relation to age, developmental stage, and cumulative exposure to risk and protection (Elder, 1998). Early work tracking alcohol and drug use over time challenged linear disease progression narratives by showing multiple pathways into, through, and out of problematic use across the lifespan (Schulenberg et al., 2015).

Core assumptions and mechanisms

Substance use is understood as developmentally contingent, shaped by timing of initiation, neurodevelopmental vulnerability, and accumulation of social and psychological stressors. Turning points — such as education, employment, relationships, caregiving roles, or health crises — can redirect the course of use without requiring a complete identity transformation or lifelong pathology. Change is expected to be nonlinear.

Evidence-based and societal impact

Longitudinal studies consistently show that early initiation, adverse childhood experiences, and chronic stress increase risk for later substance-related harm, while later protective experiences can reduce or resolve misuse even after prolonged exposure (Schulenberg et al., 2015). National data on recovery from alcohol dependence show that a substantial share of people resolve problematic use without formal treatment, which is difficult to reconcile with strictly progressive accounts of the disorder (Dawson et al., 2005). This evidence undermines deterministic interpretations of addiction and supports staged, developmentally responsive intervention.

Influence on individuals

For individuals, the life-course perspective reframes substance use as adaptation within specific developmental contexts rather than fixed identity or irreversible disease. This can reduce shame, normalize fluctuation, and support re-engagement after relapse. Clinically, it aligns with trauma-informed practice by acknowledging how early survival strategies can become maladaptive later without implying moral failure or permanent impairment.

Treatment and policy fit

This model supports prevention and early intervention, age-specific treatment approaches, long-term monitoring, and recovery supports that adapt across life stages. Policy implications include sustained investment in child welfare, education, and transitional supports rather than reliance on episodic acute care or punitive interruption.

Historical and societal roots

The structural inequity model draws on critical public health, sociology, and political economy traditions that examine how substance-related harm is produced by social stratification, racialized policies, and economic exclusion rather than by individual pathology alone (Farmer, 2004). Its emergence parallels scholarship documenting racial disparities in drug enforcement, treatment access, and overdose mortality following the War on Drugs and the rollback of social supports (Alexander, 2010; Hansen & Netherland, 2016).

Core assumptions and mechanisms

Substance misuse and its consequences are understood as patterned outcomes of structural conditions such as poverty, housing instability, labor precarity, healthcare exclusion, and discriminatory policy. Risk is produced and concentrated through environments shaped by political decisions, not randomly distributed across populations. Individual behavior is constrained by unequal access to safety, stability, and care.

Evidence-based and societal impact

Scholarship on the U.S. overdose crisis documents that substance-related morbidity, mortality, and criminalization fall disproportionately on marginalized communities, independent of prevalence of use, reflecting structural exposure rather than individual deviance (Tsai et al., 2019). This model explains why similar patterns of use yield vastly different outcomes across race, class, and geography.

Influence on individuals

For individuals, structural framing can reduce internalized blame by situating substance use within constrained choice environments. It also clarifies why motivation alone is insufficient when basic needs remain unmet. Clinically, this model encourages practitioners to recognize how systems contribute to harm while advocating for material supports rather than pathologizing survival behaviors.

Treatment and policy fit

This model aligns with harm reduction, housing-first initiatives, decarceration, expanded healthcare access, and policy reform aimed at reducing exposure to structural risk. It challenges treatment systems that demand behavior change without addressing the conditions that sustain harm and relapse.

Historical and societal roots

Engel’s (1977) biopsychosocial model was proposed as a corrective to narrow biomedical reductionism, insisting that illness is simultaneously biological, psychological, and social. With addiction, this lens became increasingly necessary because no single-level explanation — moral, brain-only, or society-only — predicts who develops problems, who recovers, and under what conditions.

Core assumptions and mechanisms

Substance use disorders emerge from interacting vulnerabilities and reinforcers across levels: genetics and neuroadaptation (Goldman et al., 2005; Koob & Volkow, 2010), mental health and coping processes (Khantzian, 1997), family and peer systems (Hawkins et al., 1992), and policy environments (Rhodes, 2002). The model is less a single theory than an organizing framework for complex causality.

Evidence-based and clinical rationale

The chronic-illness argument (McLellan et al., 2000), neurocircuitry research (Kalivas & Volkow, 2005; Koob & Volkow, 2010), and robust evidence for social risk and protective factors (Galea et al., 2004; Hawkins et al., 1992) collectively support the need for multi-level interventions. No single disciplinary lens captures the full range of factors that determine who develops a substance use disorder, who recovers, and what sustains that recovery.

Influence on individuals

This model is often experienced as more humane and realistic because it allows for accountability without moral condemnation: people can be held accountable for change while acknowledging constraints and contexts. Its main weakness has been argued on both practical and conceptual grounds. Critics contend that a framework naming everything as relevant risks specifying nothing, leaving clinicians free to emphasize whichever level they already prefer (Ghaemi, 2009). Multi-factorial explanations become vague unless translated into concrete treatment plans and policy action.

Treatment and policy fit

Integrated care, person-centered planning, harm reduction plus recovery supports, and addressing social determinants — housing, trauma exposure, employment, access to healthcare — align well with biopsychosocial thinking.

Each model is summarized across five dimensions: historical roots, core assumptions, evidence and impact, individual influence, and treatment and policy fit.

Note. Original table created for this text, summarizing the models at a glance.

Abstinence. Refraining entirely from using a substance, an outcome that some treatment approaches require as a condition of participation and others treat as one goal among several.

Biopsychosocial model. An integrating framework that understands substance use through the interaction of biological, psychological, and social factors.

Conceptual model. A framework that organizes assumptions about why substance use develops and what should be done in response.

Developmental life-course model. A framework that views substance use patterns as changing over time in response to age, life stage, and accumulated experience.

Disease model. A framework that treats addiction as a chronic, relapsing condition involving changes in brain systems for reward and self-regulation.

Harm reduction. An approach that aims to reduce the negative consequences of substance use rather than requiring abstinence as the only acceptable goal.

Moral model. An older framework that views substance use as a matter of choice and character, with recovery treated as moral reform.

Psychological model. A framework that links substance use to coping, emotion regulation, and learned patterns of thought and behavior.

Self-medication hypothesis. The idea that substances are sometimes used to manage emotional distress, painful affect, or interpersonal strain.

Sociocultural model. A framework that locates substance use in social learning, family systems, cultural norms, and the surrounding environment.

Structural inequity model. A framework that traces substance-related harm to poverty, racialized policy, and unequal access rather than individual pathology.

Alexander, M. (2010). The new Jim Crow: Mass incarceration in the age of colorblindness. The New Press.

Berridge, V. (2013). Demons: Our changing attitudes to alcohol, tobacco, and drugs. Oxford University Press.

Cheetham, A., Picco, L., Barnett, A., Lubman, D. I., & Nielsen, S. (2022). The impact of stigma on people with opioid use disorder, opioid treatment, and policy. Substance Abuse and Rehabilitation, 13, 1–12. https://doi.org/10.2147/SAR.S304566

Courtwright, D. T. (2001). Forces of habit: Drugs and the making of the modern world. Harvard University Press.

Dawson, D. A., Grant, B. F., Stinson, F. S., Chou, P. S., Huang, B., & Ruan, W. J. (2005). Recovery from DSM-IV alcohol dependence: United States, 2001–2002. Addiction, 100(3), 281–292. https://doi.org/10.1111/j.1360-0443.2004.00964.x

Elder, G. H., Jr. (1998). The life course as developmental theory. Child Development, 69(1), 1–12. https://doi.org/10.1111/j.1467-8624.1998.tb06128.x

Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460

Farmer, P. (2004). An anthropology of structural violence. Current Anthropology, 45(3), 305–325. https://doi.org/10.1086/382250

Fingarette, H. (1988). Heavy drinking: The myth of alcoholism as a disease. University of California Press.

Galea, S., Nandi, A., & Vlahov, D. (2004). The social epidemiology of substance use. Epidemiologic Reviews, 26(1), 36–52. https://doi.org/10.1093/epirev/mxh007

Ghaemi, S. N. (2009). The rise and fall of the biopsychosocial model. British Journal of Psychiatry, 195(1), 3–4. https://doi.org/10.1192/bjp.bp.109.063859

Goldman, D., Oroszi, G., & Ducci, F. (2005). The genetics of addictions: Uncovering the genes. Nature Reviews Genetics, 6(7), 521–532. https://doi.org/10.1038/nrg1635

Hall, W., Carter, A., & Forlini, C. (2015). The brain disease model of addiction: Is it supported by the evidence and has it delivered on its promises? The Lancet Psychiatry, 2(1), 105–110. https://doi.org/10.1016/S2215-0366(14)00126-6

Hansen, H., & Netherland, J. (2016). Is the prescription opioid epidemic a white problem? American Journal of Public Health, 106(12), 2127–2129. https://doi.org/10.2105/AJPH.2016.303483

Hawkins, J. D., Catalano, R. F., & Miller, J. Y. (1992). Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin, 112(1), 64–105. https://doi.org/10.1037/0033-2909.112.1.64

Jellinek, E. M. (1960). The disease concept of alcoholism. Hillhouse Press.

Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry, 162(8), 1403–1413. https://doi.org/10.1176/appi.ajp.162.8.1403

Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017). Social stigma toward persons with prescription opioid use disorder: Associations with public support for punitive and public health–oriented policies. Psychiatric Services, 68(5), 462–469. https://doi.org/10.1176/appi.ps.201600056

Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. https://doi.org/10.3109/10673229709030550

Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35(1), 217–238. https://doi.org/10.1038/npp.2009.110

Kotov, R., Gamez, W., Schmidt, F., & Watson, D. (2010). Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis. Psychological Bulletin, 136(5), 768–821. https://doi.org/10.1037/a0020327

Kvaale, E. P., Gottdiener, W. H., & Haslam, N. (2013a). Biogenetic explanations and stigma: A meta-analytic review of associations among laypeople. Social Science & Medicine, 96, 95–103. https://doi.org/10.1016/j.socscimed.2013.07.017

Kvaale, E. P., Haslam, N., & Gottdiener, W. H. (2013b). The “side effects” of medicalization: A meta-analytic review of how biogenetic explanations affect stigma. Clinical Psychology Review, 33(6), 782–794. https://doi.org/10.1016/j.cpr.2013.06.002

Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278(5335), 45–47. https://doi.org/10.1126/science.278.5335.45

Levine, H. G. (1978). The discovery of addiction: Changing conceptions of habitual drunkenness in America. Journal of Studies on Alcohol, 39(1), 143–174. https://doi.org/10.15288/jsa.1978.39.143

Malouff, J. M., Thorsteinsson, E. B., Rooke, S. E., & Schutte, N. S. (2007). Alcohol involvement and the five-factor model of personality: A meta-analysis. Journal of Drug Education, 37(3), 277–294. https://doi.org/10.2190/DE.37.3.d

McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695. https://doi.org/10.1001/jama.284.13.1689

Musto, D. F. (1999). The American disease: Origins of narcotic control (3rd ed.). Oxford University Press.

Peele, S. (1985). The meaning of addiction: Compulsive experience and its interpretation. Lexington Books.

Rhodes, T. (2002). The “risk environment”: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85–94. https://doi.org/10.1016/S0955-3959(02)00007-5

Schulenberg, J. E., Patrick, M. E., Kloska, D. D., Maslowsky, J., Maggs, J. L., & O’Malley, P. M. (2015). Substance use disorder in early midlife: A national prospective study on health and well-being correlates and long-term predictors. Substance Abuse: Research and Treatment, 9(Suppl. 1), 41–57. https://doi.org/10.4137/SART.S31437

Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019). Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Medicine, 16(11), Article e1002969. https://doi.org/10.1371/journal.pmed.1002969

Velleman, R., & Templeton, L. (2007). Understanding and modifying the impact of parents’ substance misuse on children. Advances in Psychiatric Treatment, 13(2), 79–89. https://doi.org/10.1192/apt.bp.106.002386

Verhulst, B., Neale, M. C., & Kendler, K. S. (2015). The heritability of alcohol use disorders: A meta-analysis of twin and adoption studies. Psychological Medicine, 45(5), 1061–1072. https://doi.org/10.1017/S0033291714002165

White, W. L. (1998). Slaying the dragon: The history of addiction treatment and recovery in America. Chestnut Health Systems/Lighthouse Institute.

Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. Yale University Press.